4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-098052
Director sold 281,541 shares at an average $44.76 ($12,601,536)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kersten Dirk Director | 2024-08-14 | Sale 10b5-1 | −100,650 | $43.67 | $4,395,386 | 1,553,039 | I |
| Kersten Dirk Director | 2024-08-15 | Sale 10b5-1 | −131,290 | $45.25 | $5,940,873 | 1,421,749 | I |
| Kersten Dirk Director | 2024-08-15 | Sale 10b5-1 | −49,601 | $45.67 | $2,265,278 | 1,372,148 | I |
| Open-market sales · 281,541 sh · avg $44.76 · $12,601,536 | |||||||
Loading xslF345X05/ownership.xml…